TUMOUR INFILTRATING LYMPHOCYTES AS A PROGNOSTIC AND PREDICTIVE FACTOR FOR NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER

Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 12

Abstract

Background: Triple negative breast cancer is a subtype of breast cancer that shows minimal or no immunohistochemical expression of estrogens receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2), & accounts for ~12% of invasive breast cancers. Patients with TNBC who received carboplatin had a significant three-fold increased probability of pathological complete response if the breast cancer was lymphocytic predominant. The presence of CD8+ cells in the tumor infiltrate prior to the onset of neoadjuvant chemotherapy (NAC) predicted pCR in several studies. Aim: Comparison between paclitaxel and doxorubicin versus paclitaxel and carboplatin as neoadjuvant chemotherapy in triple negative breast cancer as regard treatment response, survival rates and toxicity analysis of different prognostic factors with special emphasis on tumour infiltrating lymphocytes (TILs) and their immunophenotyping profile as a prognostic and predictive marker. Patients and methods: This retrospective study included 40 patients with TNBC stage II, III treated with NAC at Clinical Oncology and Nuclear Medicine Department Tanta University Hospitals and Oncology Department of Health Insurance hospitals throughout the period from January 2011 to December 2015. Twenty patients were treated with paclitaxel and doxorubicin (Group A) while 20 patients were treated with paclitaxel and carboplatin (Group B). Results: Paclitaxel and carboplatin showed higher overall response (OAR) and pCR (90%, 40%) respectively vs (75%, 5%) for paclitaxel and doxorubicin. Five-year OS, DFS were higher in carboplatin, paclitaxel group. High TILs tumors showed higher pCR, 5-year OS and DFS versus low, moderate TILs tumors. Conclusion: Platinum-based chemotherapy drugs are more effective in TNBC as neoadjuvant chemotherapy. Increasing numbers of stromal TILs were associated with improved pCR, OS, DFS in TNBC. Increased stromal expressions of CD3 and CD8 were all significantly associated with pCR.

Authors and Affiliations

Rana Saeed El-Sayed Ata

Keywords

Related Articles

DETECTION OF HEAVY METALS IN COSMETIC CREAMS AND ANTIPERSPIRANTS MARKETED IN SAUDI ARABIA

Background: The intentional use of metals as active ingredients in cosmetic products is prohibited in most countries due to their toxic and persistent nature and because daily transdermal exposure over a long period of t...

ROLE OF PROBIOTICS IN MANAGEMENT OF NEONATAL JAUNDICE

Objective: To evaluate the therapeutic effects of probiotics on neonatal jaundice and the safety. Methods: Sixty-eight neonates with jaundice were divided into a control group and a treatment group (n=34) randomly, and t...

CONDYLAR HYPERPLASIA- AN INSIDIOUS DEVELOPMENTAL DISORDER OF MANDIBLE

Condylar hyperplasia is a developmental disorder of mandible characterised by accelerated growth of condylar head of mandible either unilateral or bilateral. Rate of abnormal growth of the condyle determines the severity...

THE DEGREE OF AGREEMENT BETWEEN LDH/AST RATIO AND CT SCAN IN DETECTION OF PANCREATIC NECROSIS IN ACUTE BILIARY PANCREATITIS

Introduction: Pancreatitis is inflammatory disease of pancreas which may be acute or chronic. Acute pancreatitis can present with mild, moderate or severe forms. Acute severe pancreatitis may lead to pancreatic necrosis...

FREQUENCY OF MICROORGANISMS CAUSING URINARY TRACT INFECTION AMONG DIABETIC PATIENTS

Aim of study: The prevalence of asymptomatic and symptomatic UTI is very high among diabetic patients. This study was conducted to assess the frequency of microorganism involved in urinary tract infection among diabetic...

Download PDF file
  • EP ID EP666043
  • DOI -
  • Views 185
  • Downloads 0

How To Cite

Rana Saeed El-Sayed Ata (2018). TUMOUR INFILTRATING LYMPHOCYTES AS A PROGNOSTIC AND PREDICTIVE FACTOR FOR NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER. World Journal of Pharmaceutical and Medical Research, 4(12), 61-71. https://europub.co.uk/articles/-A-666043